MLchartDataset catalogue

Ameluz

Term · Oncology and biomedicine · MLC-T-ONC-000441

A drug that contains the active ingredient aminolevulinic acid hydrochloride and is used with photodynamic therapy to treat actinic keratosis (a skin condition that may become cancer). When Ameluz is taken up by abnormal cells, including cancer cells, and then exposed to certain types of light, it becomes active and kills the cells. Ameluz is a type of photosensitizing agent.

Table 1. Record
IdentifierMLC-T-ONC-000441
FieldOncology and biomedicine
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000441",
  "term": "Ameluz",
  "field": "Oncology and biomedicine",
  "definition": "A drug that contains the active ingredient aminolevulinic acid hydrochloride and is used with photodynamic therapy to treat actinic keratosis (a skin condition that may become cancer). When Ameluz is taken up by abnormal cells, including cancer cells, and then exposed to certain types of light, it becomes active and kills the cells. Ameluz is a type of photosensitizing agent.",
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ameluz/"
}

Record 949 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.